Shanghai Meiyou Lists 25% Equity In Shanghai Abbott To Abbott Laboratories
This article was originally published in PharmAsia News
Executive Summary
Shanghai Meiyou Pharmaceutical Co., Ltd. has listed its 25% equity in Shanghai Abbott Pharmaceutical Co., Ltd. for RMB 34.45 million ($5.67 million) to Abbott Laboratories, which plans to execute its right of first refusal.